Skip to main content
Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
8.15
-2.95 (-26.58%)
At close: Feb 27, 2026, 4:00 PM EST
8.23
+0.08 (0.98%)
After-hours: Feb 27, 2026, 7:55 PM EST

Emergent BioSolutions Revenue

Emergent BioSolutions had revenue of $231.10M in the quarter ending September 30, 2025, a decrease of -21.34%. This brings the company's revenue in the last twelve months to $788.90M, down -29.91% year-over-year. In the year 2024, Emergent BioSolutions had annual revenue of $1.04B, down -0.54%.

Revenue (ttm)
$788.90M
Revenue Growth
-29.91%
P/S Ratio
0.54
Revenue / Employee
$876,556
Employees
900
Market Cap
424.62M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241.04B-5.70M-0.54%
Dec 31, 20231.05B-68.20M-6.10%
Dec 31, 20221.12B-656.10M-36.99%
Dec 31, 20211.77B196.30M12.45%
Dec 31, 20201.58B471.30M42.61%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Tilray Brands 837.32M
Organogenesis Holdings 465.22M
Esperion Therapeutics 303.80M
Ironwood Pharmaceuticals 296.15M
Akebia Therapeutics 236.20M
Canopy Growth 203.04M
Kamada 174.79M
SIGA Technologies 172.25M
Revenue Rankings

EBS News

More News